Download PDF
Semin Neurol 2021; 41(06): 699-716
DOI: 10.1055/s-0041-1726362
Review Article

Approach to Common Visual Complaints Presenting to the Outpatient Neurologist

Christine Greer
1   Department of Ophthalmology, Weill Cornell Medical College, New York, New York
,
Marc Dinkin
1   Department of Ophthalmology, Weill Cornell Medical College, New York, New York
2   Department of Neurology, Weill Cornell Medical College, New York, New York
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Visual complaints are commonly encountered by the practicing neurologist. We review assessment of vision loss, diplopia, and positive visual phenomena, all of which require a thoughtful evaluation to localize disease and refine management. While many causative entities are unlikely to cause poor visual outcomes, including dry eyes, migraine, and congenital strabismus, others may threaten vision, life, or both, such as posterior communicating artery aneurysms, pituitary apoplexy, or temporal arteritis. A systematic approach to vision loss and diplopia is reviewed along with focused differential diagnoses.

Keywords

diplopia - vision loss - positive visual phenomena - neuro-ophthalmology


Publication History

Article published online:
26 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Zhao J, Fliotsos MJ, Ighani M, Eghrari AO. Comparison of a smartphone application with Ishihara pseudoisochromatic plate for testing colour vision. Neuroophthalmology 2018; 43 (04) 235-239
    CrossrefPubMedGoogle Scholar
  • 2 Young WB, Heros DO, Ehrenberg BL, Hedges III TR. Metamorphopsia and palinopsia. Association with periodic lateralized epileptiform discharges in a patient with malignant astrocytoma. Arch Neurol 1989; 46 (07) 820-822
    CrossrefPubMedGoogle Scholar
  • 3 Chodnicki KD, Pulido JS, Hodge DO, Klaas JP, Chen JJ. Stroke risk before and after central retinal artery occlusion in a US cohort. Mayo Clin Proc 2019; 94 (02) 236-241
    CrossrefPubMedGoogle Scholar
  • 4 Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998; 125 (04) 521-526
    CrossrefPubMedGoogle Scholar
  • 5 Stone JH, Tuckwell K, Dimonaco S. et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017; 377 (04) 317-328
    CrossrefPubMedGoogle Scholar
  • 6 Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008; 246 (07) 1029-1046
    CrossrefPubMedGoogle Scholar
  • 7 Saxena R, Singh D, Sharma M, James M, Sharma P, Menon V. Steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy: a randomized controlled trial. Ophthalmology 2018; 125 (10) 1623-1627
    CrossrefPubMedGoogle Scholar
  • 8 Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol 1991; 109 (12) 1673-1678
    CrossrefPubMedGoogle Scholar
  • 9 Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology 1994; 101 (11) 1771-1778
    CrossrefPubMedGoogle Scholar
  • 10 Rizzo III JF, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109 (09) 1679-1684
    CrossrefPubMedGoogle Scholar
  • 11 Beck RW, Trobe JD, Moke PS. et al; Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121 (07) 944-949
    CrossrefPubMedGoogle Scholar
  • 12 Jacobs LD, Beck RW, Simon JH. et al; CHAMPS Study Group. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000; 343 (13) 898-904
    CrossrefPubMedGoogle Scholar
  • 13 Wingerchuk DM, Banwell B, Bennett JL. et al; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85 (02) 177-189
    CrossrefPubMedGoogle Scholar
  • 14 Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34 (02) 162-168
    CrossrefPubMedGoogle Scholar
  • 15 Lennon VA, Wingerchuk DM, Kryzer TJ. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364 (9451): 2106-2112
    CrossrefPubMedGoogle Scholar
  • 16 Hamid SHM, Whittam D, Mutch K. et al. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients. J Neurol 2017; 264 (10) 2088-2094
    CrossrefPubMedGoogle Scholar
  • 17 Chen JJ, Flanagan EP, Jitprapaikulsan J. et al. Myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-positive optic neuritis: clinical characteristics, radiologic clues and outcome. Am J Ophthalmol 2018; 195: 8-15
    CrossrefPubMedGoogle Scholar
  • 18 Beck RW, Cleary PA, Anderson Jr MM. et al; The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326 (09) 581-588
    CrossrefPubMedGoogle Scholar
  • 19 Kleiter I, Gahlen A, Borisow N. et al; Neuromyelitis Optica Study Group. Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 2016; 79 (02) 206-216
    CrossrefPubMedGoogle Scholar
  • 20 Merle H, Olindo S, Jeannin S. et al. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 2012; 130 (07) 858-862
    CrossrefPubMedGoogle Scholar
  • 21 Dinkin M, Oliveira C. Men are from mars, idiopathic intracranial hypertension is from venous: the role of venous sinus stenosis and stenting in idiopathic intracranial hypertension. Semin Neurol 2019; 39 (06) 692-703
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Kashkouli MB, Yousefi S, Nojomi M. et al. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial. Graefes Arch Clin Exp Ophthalmol 2018; 256 (01) 209-218
    CrossrefPubMedGoogle Scholar
  • 23 Borruat FX, Schatz NJ, Glaser JS, Matos L, Feuer W. Radiation optic neuropathy: report of cases, role of hyperbaric oxygen therapy, and literature review. Neuroophthalmology 1996; 16 (04) 255-266
    CrossrefPubMedGoogle Scholar
  • 24 Farooq O, Lincoff NS, Saikali N, Prasad D, Miletich RS, Mechtler LL. Novel treatment for radiation optic neuropathy with intravenous bevacizumab. J Neuroophthalmol 2012; 32 (04) 321-324
    CrossrefPubMedGoogle Scholar
  • 25 Hershenfeld SA, Sharpe JA. Monocular temporal hemianopia. Br J Ophthalmol 1993; 77 (07) 424-427
    CrossrefPubMedGoogle Scholar
  • 26 Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007; 156 (02) 203-216
    CrossrefPubMedGoogle Scholar
  • 27 Bodranghien F, Bastian A, Casali C. et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum 2016; 15 (03) 369-391
    CrossrefPubMedGoogle Scholar
  • 28 Gurel SC, Castelo-Branco M, Sack AT, Duecker F. Assessing the functional role of frontal eye fields in voluntary and reflexive saccades using continuous theta burst stimulation. Front Neurosci 2018; 12: 944
    CrossrefPubMedGoogle Scholar
  • 29 Walter E, Trobe JD. The clinical and imaging profile of skew deviation: a study of 157 cases. J Neuroophthalmol 2021; 41 (01) 69-76
    CrossrefPubMedGoogle Scholar
  • 30 Brodsky MC, Donahue SP, Vaphiades M, Brandt T. Skew deviation revisited. Surv Ophthalmol 2006; 51 (02) 105-128
    CrossrefPubMedGoogle Scholar
  • 31 Wong AM. Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy. J AAPOS 2010; 14 (01) 61-67
    CrossrefPubMedGoogle Scholar
  • 32 Lemos J, Subei A, Sousa M. et al. Differentiating acute and subacute vertical strabismus using different head positions during the upright-supine test. JAMA Ophthalmol 2018; 136 (04) 322-328
    CrossrefPubMedGoogle Scholar
  • 33 Bienfang DC. Crossing axons in the third nerve nucleus. Invest Ophthalmol 1975; 14 (12) 927-931
    PubMedGoogle Scholar
  • 34 Dosunmu EO, Hatt SR, Leske DA, Hodge DO, Holmes JM. Incidence and etiology of presumed fourth cranial nerve palsy: a population-based study. Am J Ophthalmol 2018; 185: 110-114
    CrossrefPubMedGoogle Scholar
  • 35 Tamhankar MA, Biousse V, Ying GS. et al. Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology 2013; 120 (11) 2264-2269
    CrossrefPubMedGoogle Scholar
  • 36 Neuro-Ophthalmology of Basic and Clinical Science Course. In: Basic and Clinical Science Course (BCSC). American Academy of Ophthalmology; San Francisco, CA: 2017
    Google Scholar
  • 37 Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 1994; 92: 477-588
    PubMedGoogle Scholar
  • 38 Bartley GB, Fatourechi V, Kadrmas EF. et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996; 121 (03) 284-290
    CrossrefPubMedGoogle Scholar
  • 39 Gilhus NE. Myasthenia gravis. N Engl J Med 2016; 375 (26) 2570-2581
    CrossrefPubMedGoogle Scholar
  • 40 Bever Jr CT, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Prognosis of ocular myasthenia. Ann Neurol 1983; 14 (05) 516-519
    CrossrefPubMedGoogle Scholar
  • 41 Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord 2006; 16 (07) 459-467
    CrossrefPubMedGoogle Scholar
  • 42 Chen AH, Aziz A. Heterophoria in young adults with emmetropia and myopia. Malays J Med Sci 2003; 10 (01) 90-94
    PubMedGoogle Scholar
  • 43 Ali MH, Berry S, Qureshi A, Rattanalert N, Demer JL. Decompensated esophoria as a benign cause of acquired esotropia. Am J Ophthalmol 2018; 194: 95-100
    CrossrefPubMedGoogle Scholar
  • 44 Borrego-Sanz L, Gómez-Gómez A, Gurrea-Almela M. et al; Madrid Uveitis Study Group. Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers. Graefes Arch Clin Exp Ophthalmol 2019; 257 (11) 2505-2516
    CrossrefPubMedGoogle Scholar
  • 45 Zaret BS. Lightning streaks of Moore: a cause of recurrent stereotypic visual disturbance. Neurology 1985; 35 (07) 1078-1081
    CrossrefPubMedGoogle Scholar
  • 46 Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. ‘Visual snow’ - a disorder distinct from persistent migraine aura. Brain 2014; 137 (Pt 5): 1419-1428
    CrossrefPubMedGoogle Scholar
  • 47 Yun SH, Lavin PJ, Schatz MP, Lesser RL. Topiramate-induced palinopsia: a case series and review of the literature. J Neuroophthalmol 2015; 35 (02) 148-151
    CrossrefPubMedGoogle Scholar
  • 48 Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom 2004; 87 (03) 149-152
    CrossrefPubMedGoogle Scholar